Overview

Explore the Role of Fespixon in Linear Scar Aesthetics

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of the Fespixon cream for prevention and/or appearance reduction of different types of linear scars during the 12-week treatment phase, which is assessed by the blinded independent evaluator.
Phase:
Phase 3
Details
Lead Sponsor:
National Defense Medical Center, Taiwan